These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 2743870
1. Clinical evaluation of imipenem/cilastatin in the therapy of severe infections in high-risk patients. Cristiano P. Drugs Exp Clin Res; 1989; 15(1):17-20. PubMed ID: 2743870 [Abstract] [Full Text] [Related]
2. Clinical evaluation of the imipenem/cilastatin combination in the therapy of severe infections in patients with malignant diseases. Cristiano P, Iovene MR, Simioli F, Pezza M, Raucci G, Lobello R. Drugs Exp Clin Res; 1990; 16(6):293-7. PubMed ID: 2086164 [Abstract] [Full Text] [Related]
3. Aztreonam in the therapy of nosocomial infections in patients with impaired host defenses. Cristiano P, Iovene MR, Paradisi F. Chemioterapia; 1985 Apr; 4(2):182-5. PubMed ID: 3891117 [Abstract] [Full Text] [Related]
7. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients. Kuo BI, Fung CP, Liu CY. Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445 [Abstract] [Full Text] [Related]
10. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections. Niinikoski J, Havia T, Alhava E, Pääkkönen M, Miettinen P, Kivilaakso E, Haapiainen R, Matikainen M, Laitinen S. Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381 [Abstract] [Full Text] [Related]
11. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections. Cakmakci M, Stern A, Schilling J, Christen D, Roggo A, Geroulanos S. Drugs Exp Clin Res; 1993 Mar; 19(5):223-7. PubMed ID: 8174495 [Abstract] [Full Text] [Related]
12. [Clinical and pharmacokinetic study of imipenem/cilastatin in children and newborn infants]. Bégué P, Quinet B, Baron S, Challier P, Fontaine JL, Lasfargues G. Pathol Biol (Paris); 1989 May; 37(5):485-90. PubMed ID: 2674874 [Abstract] [Full Text] [Related]
18. [Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years]. Janvier G, Carles J. Ann Chir; 1993 May; 47(4):370-5. PubMed ID: 8352517 [Abstract] [Full Text] [Related]
19. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli. Schaumann R, Blatz R, Beer J, Ackermann G, Rodloff AC. J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746 [Abstract] [Full Text] [Related]
20. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections. Hou F, Li J, Wu G, Zheng B, Chen Y, Gu J, Wang H, Huo L, Xue X, Jia C, Yin Y, Tian X, Ren S. Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937 [Abstract] [Full Text] [Related] Page: [Next] [New Search]